PPETS 2026

1. Describe the current landscape, indications, and challenges in pediatric extracorporeal therapies, including ECMO and CRRT.
2. Apply evidence-informed and consensus-based approaches to the initiation, management, and discontinuation of extracorporeal support.
3. Evaluate practice variability and its impact on patient outcomes to inform more standardized care processes.
4. Integrate emerging technologies, data-driven tools, and simulation-based learning into clinical practice to improve performance and safety.
5. Implement strategies aimed at improving patient-centered outcomes, including reduction of complications and optimization of short- and long-term recovery.
6. Develop future avenues for research in the field of pediatric extracorporeal therapies.

1. Nurses will report a >75% increased confidence in interdisciplinary communication and intent to apply standardized care processes in clinical practice based on post-activity evaluation.
2. At the conclusion of this activity, =80% of participants will demonstrate improvement in confidence related to managing pediatric extracorporeal therapies.

Texas Children’s Hospital is accredited by the Texas Medical Association to provide continuing medical education for physicians. Texas Children’s Hospital designates this Live Activity activity for a maximum of 12.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Texas Children’s Hospital is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This nursing continuing professional development (NCPD) activity awards up to {NursingHours} contact hours.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Texas Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Texas Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Texas Children's Hospital adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Texas Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible company (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sameer V Thadani, MD

Co-Director, Faculty

Nothing to disclose

Kristin J Dolan, MD
Assistant Professor
Baylor College of Medicine
Houston, TX

Course Director, Faculty

Nothing to disclose

Gail Annich, MD

Faculty

Michael Bell, MD

Faculty

Nothing to disclose

Brian Bridges, MD

Faculty

Corey Chartan

Faculty

Kevin Chung, MD

Faculty

Ryan Coleman, MD
Texas Children’s
Houston, TX

Faculty

Dana Fuhrman, DO
Cincinnati Children's Hospital Medical Center,

Faculty

Stuart Goldstein, MD

Faculty

Consulting Fee-BioPorto Diagnostics|Consulting Fee-Caclimedica|Consulting Fee-Vantive|Consulting Fee-SeaStar Medical|Consulting Fee-Otsuka America Pharmaceutical, Inc.|Consulting Fee-Mozarc Medical|Consulting Fee-Silver Creek Pharma|Grant or research support-SeaStar Medical (Relationship has ended)|Grant or research support-Vantive|Grant or research support-Talphera|Grant or research support-Baebies|Grant or research support-Boehringer Ingelheim Pharmaceuticals, Inc.|Stocks or stock options, excluding diversified mutual funds-MediBeacon|Speakers Bureau-Fresenius (Relationship has ended)

Hernando Gomez, MD

Faculty

Rhodes Hambrick, MD

Faculty

Adhil Kakajiwala, MD

Faculty

Tammy Kang, MD
Baylor College of Medicine

Faculty

John Kellum, MD

Faculty

Employment-Spectral Medical|Paid consultant-Bayer (Any division)|Paid consultant-AstraZeneca (Any division)

Roxanne Kirsch, MD
The Hospital for Sick Children, University of Toronto
Toronto, Canada

Faculty

Sal Maffei
,

Faculty

Nothing to disclose

Amir Navaei, MD
Houston, TX

Faculty

Nothing to disclose

Tara Neumayr, MD

Faculty

James Odum, MD

Faculty

Erika O'Neil, MD
, TX

Faculty

Nothing to disclose

Andrea Ontaneda, MD
Baylor College of Medicine
Houston, TX

Faculty

Nothing to disclose

Howard I Pryor II, MD
Trauma Medical Director
Baylor College of Medicine
Houston, TX

Faculty

Nothing to disclose

Lakshmi Raman, MD

Faculty

Natalja L Stanski, MD
Assistant Professor
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

Faculty

Nothing to disclose

Gideon Stitt, Pharm.D
Children's Hospital of Philadelphia
Philadelphia, PA

Faculty

James Thomas, MD
Baylor College of Medicine
Houston, TX

Faculty

Molly R Vega

Faculty

Adam M Vogel, MD, FACS, FAAP
Professor
Texas Children's Hospital
Houston, TX

Faculty

Nothing to disclose

Kim Vuong

Faculty

Thank you for your interest in submitting an abstract for the 2026 PPET Conference.

GENERAL INFORMATION
1. Deadline: August 24, 2026
2. Email abstract submission to: [email protected]
3. Notification of acceptance will be September 1, 2026
4. Selected abstracts will be chosen for short oral presentation with free conference attendance